QT prolongation due to targeted anticancer therapy
Journal Title: OncoReview - Year 2016, Vol 6, Issue 3
Abstract
A growing number of targeted anticancer agents has shown the unexpected ability to induce QT interval prolongation. In addition, standard chemotherapeutics and a variety of conditions such as electrolyte abnormalities, endocrine disorders, cardiac diseases, nutritional disturbances and other factors may be associated with long QT syndrome in cancer patients. Prolongation of the QT interval can lead to life-threatening ventricular arrhythmias, including ‘torsade de pointes’ (TdP). The association between long QT interval and ventricular arrhythmias remains the subject of many controversies.The QT interval represents the time interval of both ventricular depolarization and repolarization. Not only abnormalities of ion channels, but also changes in the myocardial microarchitecture and other factors and disorders frequently seen in cancer patients may participate in its prolongation and potential risk of ventricular arrhythmias.The aim of this review was to summarize current knowledge about QT prolongation in cancer patients with the special focus on targeted therapy.
Authors and Affiliations
Lucia Setteyova, Ljuba Bacharova, Beata Mladosievicova
Keywords
Related Articles
- EP ID EP80363
- DOI -
- Views 213
- Downloads 0
Zmiany w błonie śluzowej przewodu pokarmowego wywołane radio- i chemioterapią nowotworów
Zapalenie błony śluzowej przewodu pokarmowego (mucositis) po radio- i chemioterapii nowotworów manifestuje się klinicznym zespołem objawów będących następstwem zmian morfologicznych błony śluzowej. Ból, owrzodzenie, wzdę...
IgM multiple myeloma: diagnostic difficulties and results of bortezomib treatment – case report
The IgM paraprotein secretion is most frequently associated with Waldenström’s macroglobulinemia. In very rare cases it may also occur in multiple myeloma. The diagnostic and therapeutic process of a 84 year old male suf...
Targeted therapies in neuroendocrine neoplasms
The primary treatment of gastrointestinal neuroendocrine tumors is surgery, and its extent depends on the clinical stage of cancer. In advanced disease medical therapy is used. One possible form of treatment is biologica...
Pheochromocytoma and paraganglioma – an overview
Pheochromocytoma and paraganglioma derive from chromaffin tissue that secretes catecholamines, which determine the characteristic clinical picture of the disease. Serious and potentially fatal cardiovascular complication...
Complications of palliative antiangiogenic therapy in patients with colorectal cancer
Introduction: Bevacizumab is an antiangiogenic drug used in the therapy of numerous solid tumours including colorectal adenocarcinoma. The efficacy and safety of bevacizumab has been demonstrated in many multicenter clin...